Cassava Sciences Inc
Change company Symbol lookup
Select an option...
SAVA Cassava Sciences Inc
BOSC BOS Better Online Solutions Ltd
BORR Borr Drilling Ltd
BOOT Boot Barn Holdings Inc
EPD Enterprise Products Partners LP
$JSEMET EMIX Smaller Europe Metal Production
CUB Cubic Corp
FB Facebook Inc
NWVCF Enwave Corp
MMM 3M Co
Go

Health Care : Pharmaceuticals | Small Cap Blend
Company profile

Cassava Sciences, Inc., formerly Pain Therapeutics, Inc., is a clinical-stage biopharmaceutical company. The Company is focused on developing drug for the treatment of nervous system disorders. The Company is ocused on the early detection and treatment of neurodegenerative diseases, such as Alzheimer’s. Its drug candidate, PTI-125, is a small molecule that targets an altered form of a scaffolding protein called filamin A (FLNA). The Company is also developing an experimental biomarker/diagnostic, PTI-125Dx. It is developing PTI-125Dx to detect Alzheimer’s disease with a blood test.

Closing Price
$10.57
Day's Change
0.09 (0.86%)
Bid
--
Ask
--
B/A Size
--
Day's High
10.99
Day's Low
9.98
Volume
(Light)
Volume:
2,297,434

10-day average volume:
3,742,185
2,297,434
  • Prev Close
    10.48
  • Today's Open
    10.38
  • Day's Range
    9.98-10.99
  • Avg Vol (10-day)
    3.7M
  • Last (time)
    4:00p ET 01/15/21
  • Last (size)
    1.2K
  • 52-Wk Range
    1.63 - 12.99
    LowHigh
  • (05/15/20 - 01/13/21)
    18.63%
  • 203.3%
  • Market Cap
    369.5M
  • Shares Outstanding
    35.0M
  • -0.23
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 1.5
  • 25.43
  • (% of float 12/31/20)
    16.67

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.